05 October 2007, London, Manchester, Munich: Northbank Communications, leaders in life science communications, announces that it has entered into an agreement to become part of College Hill, the international business communications consultancy, by way of 100% acquisition of the shares in Northbank Communications by College Hill.
Northbank has built a strong reputation and global client base in the life science sector, with clients including Ablynx, Biota, BTG, Cambridge Antibody Technology (AZ), Ganymed, GE Healthcare, LifeCycle Pharma, Midatech, Nautilus Biotech, Nitec Pharma, Novozymes, Oxford BioMedica, Perkin Elmer, Santaris Pharma, Sigma-Aldrich and Smiths Detection. It offers services across corporate, financial and marketing communications, including an in-house design studio. The deal substantially strengthens Northbank’s offering in financial communications, and adds new areas of expertise for its clients through College Hill’s Public Policy, Internal Engagement and Strategic Research practices. The international reach of College Hill also enhances Northbank’s global capability, through offices in Hong Kong and Johannesburg.
Sue Charles, CEO of Northbank Communications commented, "We are very excited to be part of College Hill and the opportunities it presents for our clients and our staff. We explored a number of options for our business, and are convinced that this move provides real benefits in terms of range of services, expertise and resources. We will fit well with the College Hill culture, a culture that emphasises client partnership and creativity".
Following the acquisition, which was brokered by corporate finance advisory firm Pembridge Partners LLP, College Hill will retain Northbank’s current structure and facilities, including its team of 32 across offices in London, Manchester and Munich. Sue Charles, CEO of Northbank will head College Hill’s Life Sciences industry team and will become Managing Partner, Life Sciences. Northbank senior team members Katja Stout, Director and Chris Fisher, Creative Director will be appointed as Partner and Associate Partner/Creative Director, Life Sciences respectively. Co-founder and Director of Northbank, Peter Colley will retire at the year end. Northbank’s venture investors, Pembridge Partners exit as part of the deal.
Alex Sandberg, Chairman of College Hill, and CEO Richard Nichols said that "Sue and the Northbank team have built a highly regarded presence in the life sciences sector and we are delighted to welcome them into the group. Northbank significantly strengthens our client offering in the sector and, in turn, Northbank's clients now have access to a wider range of disciplines and reach. We are continuing to invest in sector specialisation, practice areas and geography as we build out a rounded international business communications consultancy".
Sue Charles, Managing Partner
UK: +44 (0)20 7457 2020/ +44 (0)7968 726 585
Australia: +61 (0)457 924 218